WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan
· Delayed Price · Currency is TWD 60.90
-0.20 (-0.33%)
Jun 27, 2025, 1:06 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 2.76 billion as of June 27, 2025. Its market cap has decreased by -6.64% in one year.
Market Cap
2.76B
Enterprise Value
3.09B
Revenue
1.00B
Ranking
n/a
PE Ratio
15.31
Stock Price
60.90
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 2.76B, a decrease of -19.66%. That is a compound annual growth rate of -13.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 2.77B | -14.60% |
| Dec 31, 2024 | 3.24B | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 196.20B |
| PharmaEssentia | 181.63B |
| Bora Pharmaceuticals Co., LTD. | 84.30B |
| Lotus Pharmaceutical | 57.58B |
| Oneness Biotech | 31.33B |
| Polaris Group | 29.05B |
| Center Laboratories | 27.35B |
| TaiMed Biologics | 25.92B |